Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

We Told You About This $6 Biotech – Now Wall Street Likes It, Too

Sometimes it doesn't take long.

In a Private Briefing report last Wednesday, we recommended shares of TrovaGene Inc. (Nasdaq: TROV), a biotech that's developed a new diagnostic technologies to "screen" patients for infectious diseases and even cancer.

But the "X-factor" - the catalyst that prompted me to make the recommendation - was the fact that a healthcare-focused hedge fund has been making massed purchases of the stock.

Full Story

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK